Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02). - Opdam M; Ultee N; Geenen JJJ; van Rossum AGJ; Mandjes IAM; Balduzzi S; Hofland I; Wesseling J; Menezes RX; Oosterkamp HM; Linn SC (Breast (Edinburgh, Scotland), 2026)